Parse error: syntax error, unexpected '/', expecting T_VARIABLE or '$' in /homepages/1/d315158125/htdocs/Pharmaclient/biotech/fonctions.inc(162) : eval()'d code on line 4
$texte= " * ADOCIA *
2005 - Rhône-Alpes
Lyon
www.no-website.net Discovery, Drugs
Key words: Growth factors, Natural proteins, Regenerating organs, Osteoporosis, Diabetes, Aging population, BioChaperone
Mission: to develop innovative drugs for regenerating organs affected by diseases related to the aging of the population, such as osteoporosis and diabetes
Clients: Pharmaceutical industry
g.soula@adocia.com
Age: " . AGE() . " year(s)
Identity| TYPE/MANAGEMENT/INVESTORS | FINANCES/STATUS |
|---|
| Personal venture |
Managing Dir.-CEO: Soula (Gérard) [born 1945, ex-Rhône Poulenc, Flamel Technologies (founder)]
Sc.Dir.-CSO: Soula (Olivier) [born 1970, PhD polymer science, MBA-IAE (Lyon), ex-Flamel Technologies]
Fin.Dir.-CFO: Danaguezian (Valérie)
BusDev:
Financers (Hist.): AGF P.E., Bioam Gestion, Société Générale A.M., Viveris Management, Business angels (Alain Tornier and Jean Deléage [died in 2011]), InnoBio, SHAM (Société Hospitalière d'Assurances Mutuelles) | Turnover (M€) : n.a.
Total funding (M€) : 27.6
Last funding (M€) : 14.0
Focus : Multiple
Position : Clinical
Company confirm : neutral |
History | DATE | MILESTONE | TYPE | TIME |
|---|
| 2011 .06 | Clinical trials (phase II) with BioChaperone technology combined with 2 therapeutic proteins, Platelet Derived Growth Factor, fast-acting human insulin (completed) | CLIN | [5 years] |
| 2010 .01 | 2nd round-financing : 14.0 M€, by InnoBio (for 6 M€), SHAM (for 2 M€), and previous shareholders, including the founders | RFINB | [4 years] |
| 2008 .04 | 1st round-financing : 12.0 M€, by AGF P.E., Société Générale A.M., Bioam Gestion, Vivéris Management | RFINA | [2 years] |
| 2007 .00 | Financing (no interest loan) : 2.25 M€, by OSEO, for its osteoporosis project | DEBT | [1 year] | Actualisation / Updating: |
"
|
